Q&A: Biotech Patent Guru Discusses Possible Proteomics Patent Wars | GenomeWeb

NEW YORK, March 8 - Leslie Misrock, a 73 year-old partner at Pennie & Edmonds in New York who has been called the father of Biotechnology Patent Law, is concerned about proteomics. With decades of biotechnology litigation under his belt, Misrock has warned industry leaders that battles over protein patents could stop proteomics dead in its tracks. This week, Genomeweb caught up with Misrock to discuss this issue.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.